We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$48.4B
AUM Growth
+$2.68B
Cap. Flow
-$1.02B
Cap. Flow %
-2.1%
Top 10 Hldgs %
17.92%
Holding
2,721
New
174
Increased
1,803
Reduced
673
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 21.79%
2 Healthcare 13.73%
3 Financials 11.94%
4 Industrials 11.68%
5 Consumer Discretionary 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTT
2626
High Templar Tech Ltd
HTT
$387M
$58K ﹤0.01%
+12,369
New +$72.8K
FLNT
2627
Fluent
FLNT
$122M
$57K ﹤0.01%
3,826
+600
+19% +$8.1K
NVAX icon
2628
Novavax
NVAX
$1.29B
$57K ﹤0.01%
14,293
+3,932
+38% +$17.1K
ELVT
2629
DELISTED
Elevate Credit, Inc.
ELVT
$57K ﹤0.01%
+12,804
New +$53.5K
RLH
2630
DELISTED
Red Lions Hotel Corporation
RLH
$57K ﹤0.01%
+15,219
New +$71K
EYPT icon
2631
EyePoint Inc
EYPT
$1.08B
$56K ﹤0.01%
+3,624
New +$64.6K
FTK icon
2632
Flotek Industries
FTK
$1.4B
$56K ﹤0.01%
4,688
+1,000
+27% +$11.5K
CFMS
2633
DELISTED
Conformis, Inc. Common Stock
CFMS
$55K ﹤0.01%
1,467
+450
+44% +$21.3K
TYME
2634
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$55K ﹤0.01%
39,043
+15,113
+63% +$18.3K
USX
2635
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$54K ﹤0.01%
+10,709
New +$52.2K
PBPB
2636
DELISTED
Potbelly
PBPB
$53K ﹤0.01%
12,548
+2,112
+20% +$9.22K
LJPC
2637
DELISTED
La Jolla Pharmaceutical Company
LJPC
$53K ﹤0.01%
+13,515
New +$79.8K
KZR
2638
DELISTED
Kezar Life Sciences
KZR
$50K ﹤0.01%
+1,236
New +$38K
SLDB icon
2639
Solid Biosciences
SLDB
$941M
$50K ﹤0.01%
+755
New +$83.3K
KALA icon
2640
KALA BIO
KALA
$14.7M
$49K ﹤0.01%
+5
New +$48.3K
LXU icon
2641
LSB Industries
LXU
$726M
$49K ﹤0.01%
+15,050
New +$50.8K
KDNY
2642
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$49K ﹤0.01%
8,326
+3,279
+65% +$17.8K
ASRT
2643
DELISTED
Assertio
ASRT
$48K ﹤0.01%
638
-3,278
-84% -$192K
RMNI icon
2644
Rimini Street
RMNI
$450M
$48K ﹤0.01%
+12,334
New +$49.4K
FTR
2645
DELISTED
Frontier Communications Corp.
FTR
$48K ﹤0.01%
54,026
-320,064
-86% -$261K
ADMS
2646
DELISTED
Adamas Pharmaceuticals
ADMS
$47K ﹤0.01%
+12,347
New +$59.1K
CVIA
2647
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$47K ﹤0.01%
22,987
+2,937
+15% +$4.74K
CYCN icon
2648
Cyclerion Therapeutics
CYCN
$15.9M
$46K ﹤0.01%
+839
New +$78.3K
MRKR icon
2649
Marker Therapeutics
MRKR
$18.2M
$46K ﹤0.01%
1,601
+595
+59% +$21.6K
SB icon
2650
Safe Bulkers
SB
$739M
$46K ﹤0.01%
27,220
+6,228
+30% +$10.8K

Similar funds

VOYA Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, VOYA Investment Management held 2,721 positions worth $48.4B, up 5.9% from $45.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

VOYA Investment Management's Q4 2019 filing shows 174 new, 1,803 increased, 673 reduced and 44 closed positions. Its largest new stake was iShares MSCI EAFE Value ETF: 1,214,827 shares worth $60.7M. The largest sale was Alphabet (Google) Class A, an estimated $315M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • VOYA Investment Management's largest Q4 2019 buy was iShares MSCI EAFE Value ETF: 1,214,827 shares worth $60.7M.
  • VOYA Investment Management added most to Meta Platforms (Facebook) in Q4 2019, an estimated $541M increase.
  • VOYA Investment Management's biggest Q4 2019 reduction was Alphabet (Google) Class A, cutting an estimated $315M.
  • VOYA Investment Management fully exited Celgene Corp in Q4 2019, selling an estimated $39.7M.
  • VOYA Investment Management's ten largest holdings make up 18% of its $48.4B portfolio in Q4 2019.
  • VOYA Investment Management opened 174 new positions and closed 44 in Q4 2019.
  • VOYA Investment Management's portfolio value rose 5.9% quarter-over-quarter to $48.4B.

Based on VOYA Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.